Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps

With the ongoing need to improve therapy for non–small cell lung cancer (NSCLC) there has been increasing interest in developing reliable preclinical models to test novel therapeutics. Patient-derived tumor xenografts (PDX) are considered to be interesting candidates. However, the establishment of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilie, Marius, Nunes, Manoel, Blot, Lydia, Hofman, Véronique, Long-Mira, Elodie, Butori, Catherine, Selva, Eric, Merino-Trigo, Ana, Vénissac, Nicolas, Mouroux, Jérôme, Vrignaud, Patricia, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329004/
https://www.ncbi.nlm.nih.gov/pubmed/25470237
http://dx.doi.org/10.1002/cam4.357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329004/
https://www.ncbi.nlm.nih.gov/pubmed/25470237
http://dx.doi.org/10.1002/cam4.357

Ejemplares similares